Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study

BACKGROUND: Several countries have authorised or begun using a booster vaccine dose against COVID-19. Policy makers urgently need evidence of the effectiveness of additional vaccine doses and its clinical spectrum for individuals with complete primary immunisation schedules, particularly in countrie...

Descripción completa

Detalles Bibliográficos
Autores principales: Jara, Alejandro, Undurraga, Eduardo A, Zubizarreta, José R, González, Cecilia, Pizarro, Alejandra, Acevedo, Johanna, Leo, Katherinne, Paredes, Fabio, Bralic, Tomás, Vergara, Verónica, Mosso, Marcelo, Leon, Francisco, Parot, Ignacio, Leighton, Paulina, Suárez, Pamela, Rios, Juan Carlos, García-Escorza, Heriberto, Araos, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034854/
https://www.ncbi.nlm.nih.gov/pubmed/35472300
http://dx.doi.org/10.1016/S2214-109X(22)00112-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034854/
https://www.ncbi.nlm.nih.gov/pubmed/35472300
http://dx.doi.org/10.1016/S2214-109X(22)00112-7

Ejemplares similares